Total planned funding: $217,564,186
Clear active filters
University of California at San Francisco
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Kenya | $136,000,258 |
Mozambique | $24,425,039 |
South Africa | $12,393,900 |
Uganda | $11,769,529 |
Tanzania | $10,002,055 |
Namibia | $4,143,495 |
Western Hemisphere Region | $3,902,071 |
Caribbean Region | $2,700,000 |
Vietnam | $2,598,273 |
Zambia | $1,698,566 |
Asia Regional Program | $1,563,000 |
Ukraine | $1,100,000 |
enumerations.Philippines | $1,005,000 |
Ghana | $950,000 |
Botswana | $703,000 |
Malawi | $700,000 |
Burundi | $700,000 |
Burma | $600,000 |
Côte d'Ivoire | $500,000 |
Papua New Guinea | $70,000 |
Rwanda | $40,000 |
Cameroon | $0 |
Zimbabwe | $0 |
Organizational Types
University | $216,444,186 |
Implementing Agency | $1,000,000 |
Other USG Agency | $120,000 |
Program Areas
Treatment | $83,139,410 |
Governance and Systems | $66,505,903 |
Prevention | $29,674,831 |
Care | $22,478,335 |
Testing | $12,158,783 |
Management and Operations | $150,000 |
Budget Codes
HTXS: Treatment: Adult Treatment | $75,338,039 |
HVSI: Strategic Information | $61,005,122 |
HBHC: Care: Adult Care and Support | $12,959,144 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $12,398,021 |
HVCT: Testing: HIV Testing and Counseling | $12,158,783 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $10,470,746 |
PDTX: Treatment: Pediatric Treatment | $7,801,371 |
HVTB: Care: TB/HIV | $6,445,014 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,761,584 |
OHSS: Health Systems Strengthening | $4,415,456 |
PDCS: Care: Pediatric Care and Support | $2,614,177 |
HLAB: Laboratory Infrastructure | $1,085,325 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $800,000 |
HKID: Care: Orphans and Vulnerable Children | $460,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $244,480 |
HVMS: Management and Operations | $150,000 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
HTXD: Treatment: ARV Drugs | $0 |